NYSE American to Suspend Trading Immediately in Blonder Tongue Laboratories, Inc. (BDR)
NEW YORK--(BUSINESS WIRE)-- NYSE American LLC (“NYSE American” or the “Exchange”) announced today that the staff of NYSE Regulation has now determined to immediately suspend trading in the common stock of Blonder Tongue Laboratories, Inc. (the “Company”) ─ ticker symbol BDR ─ from the Exchange. This follows the Exchange’s December 10, 2021 announcement initiating delisting proceedings.
The Company had requested a review of the NYSE American delisting determination before a Committee of the Board of Directors of the Exchange. On June 24, 2022, the Company provided formal notification of its intention to withdraw its request for such review.
Accordingly, the NYSE American will now suspend trading in the common stock and will file a delisting application with the Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220624005486/en/
Company Contact:
Eric Skolnik
Chief Financial Officer
[email protected]
(732) 679-4000
Ted Grauch
Chief Executive Officer
[email protected]
(732) 679-4000
NYSE Contact:
NYSE Communications
[email protected]
Source: NYSE Regulation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coinbase (COIN) CEO Armstrong on X: Great progress on the SEC case - and huge win for self-custodial wallets
- Fosun Management on 2023 Annual Results: Focusing on Core Industries with Established Advantages
- KBRA Assigns Long-Term Ratings of AA to Three Series of Chicago Park District General Obligation Bonds; Outlook is Positive
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!